Literature DB >> 28223329

Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database.

Yasuo Oshima1, Tetsuya Tanimoto2, Koichiro Yuji2, Arinobu Tojo2.   

Abstract

Entities:  

Keywords:  aortic dissection; axitinib; bevacizumab; lenvatinib; pazopanib; ramucirumab; sorafenib; sunitinib; vandetanib; vascular endothelial growth factor

Mesh：

Substances：

Year:  2017        PMID： 28223329     DOI： 10.1161/CIRCULATIONAHA.116.025144

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  Aortic dissection after ramucirumab infusion.

Authors:  Davide Zenoni; Flavio Niccolò Beretta; Vanessa Martinelli; Alessandro Iaculli; Maria Teresa Benzoni Fratelli; Delia Bonzi
Journal:  Eur J Hosp Pharm       Date:  2019-06-14

Review 2.  Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association.

Authors:  Umberto Campia; Javid J Moslehi; Laleh Amiri-Kordestani; Ana Barac; Joshua A Beckman; David D Chism; Paul Cohen; John D Groarke; Joerg Herrmann; Carolyn M Reilly; Neal L Weintraub
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

3.  Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma.

Authors:  Takatoshi Nawa; Kazuhiro Katayama; Ryosuke Kiyota; Toshihiro Imai; Yutaro Abe; Noriko Hasegawa; Ryoji Takada; Nobuyasu Fukutake; Kenji Ikezawa; Mitsuru Sakakibara; Masashi Fujita; Kazuyoshi Ohkawa
Journal:  Clin J Gastroenterol       Date:  2019-07-17

Review 4.  Cancer Therapies and Vascular Toxicities.

Authors:  Alexandra Meilhac; Jennifer Cautela; Franck Thuny
Journal:  Curr Treat Options Oncol       Date:  2022-03-04

Review 5.  Aortic Aneurysms and Dissections Series: Part II: Dynamic Signaling Responses in Aortic Aneurysms and Dissections.

Authors:  Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-25       Impact factor: 8.311

6.  Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance Study.

Authors:  Adam Goldman; David Bomze; Rachel Dankner; Dana Fourey; Ben Boursi; Michael Arad; Elad Maor
Journal:  Target Oncol       Date:  2021-05-10       Impact factor: 4.493

7.  Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection-A pharmacovigilance analysis.

Authors:  Michael Dörks; Kathrin Jobski; Stefan Herget-Rosenthal; Falk Hoffmann; Antonios Douros
Journal:  Pharmacol Res Perspect       Date:  2021-02

8.  Aneurysm and Artery Dissection Following the Use of Vascular Endothelial Growth Factor Inhibitor: A Real-World Analysis Using a Spontaneous Reporting System.

Authors:  Shuyue Wang; Mingzhu Chen; Xinghui Zhang; Lingjian Zhang; Min Jia; Zhiwen Shen; Junyan Wang; Bin Zhao; Yang Gong; Jian Gong
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 6.106

9.  Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma.

Authors:  Atsunori Tsuchiya; Masahiro Ogawa; Yusuke Watanabe; Naruhiro Kimura; Kazunao Hayashi; Takeshi Suda; Shuji Terai
Journal:  Clin Case Rep       Date:  2018-07-01

10.  Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B12 analog.

Authors:  Gerburg K Schwaerzer; Hema Kalyanaraman; Darren E Casteel; Nancy D Dalton; Yusu Gu; Seunghoe Lee; Shunhui Zhuang; Nisreen Wahwah; Jan M Schilling; Hemal H Patel; Qian Zhang; Ayako Makino; Dianna M Milewicz; Kirk L Peterson; Gerry R Boss; Renate B Pilz
Journal:  Nat Commun       Date:  2019-08-06       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.